Inventia Healthcare Limited recalls Chlorthalidone Tablets
- Recalling company
- Inventia Healthcare Limited
- Product
- Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
- Reason
- Failed Dissolution Specifications
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 5, 2026
- Reported
- Jun 24, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 11,460 bottles
- Lot / codes
- [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027
- Company location
- Kalyan
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0610-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0610-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.